HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Swanson Vision Defense, Se-cure Femarelle: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

DSM stirs gut health play with BioCare; Strength coach market for Neptune's Omega Drive; Nutranext corporate brand for Wellnext; and more news in brief.

You may also be interested in...



Products Provider Nutrisystem Moves To Fitness Services Firm Tivity For $1.4Bn

Nutrisystem's sale to Tivity Health comes after a year of expanding its nutritional products and related services with daily vitamin packs, nutritional bars and shakes and genetic-based analysis for a personal action plan focused on eating behaviors, nutrition and metabolism. Tivity's move into providing products, though, didn’t go over well with investors.

Supplement Industry Investment Continues On Swander Pace Contract Manufacturing Move

Swander Pace expands Captek’s operations less than two years after acquiring the firm and seven months after investing in a protein supplement manufacturer as one of numerous private equity firms active in the nutritional products space.

Almost All Top German OTC Companies Have Now Raised Prices Due To Inflation – Sempora

87 of the top 100 German OTC manufacturers are now reporting inflation-driven price increases, up from 72 at the same point last year. Sempora Consulting suggests a number of strategies to address the current economic challenges companies face. 

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS121390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel